Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Compass Pathways says a single dose of its synthetic psilocybin significantly reduced depression symptoms in patients who ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

Compass Pathways' delayed phase 3 readout for its psilocybin treatment has hit its primary endpoint of reducing the severity ...

I’ll move to the Azores if you want,” I said to my wife, Samantha, after a conflict with an extended family member, who ...

Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...

SANTA FE — New Mexico this week becomes the third state to launch a state-run medical psilocybin program, but don't expect magic mushrooms to be widely offered any time soon. State officials have ...

Gov. Jared Polis announced Wednesday at the Psychedelic Science Conference in Denver he is issuing a mass pardon for ...

Psychedelic Science conference and trade show in Denver started with a bang — or perhaps with the creaking sound of jail ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...